What is the main business of Oxymotion?

The main business activity of Oxymotion focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 27, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Bohdana Dobrzańskiego 3, 20-262 Lublin.

Who is on the management board?

The management board consists of: Mateusz Delikat (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 8,000 (approx. $2,161).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

Oxymotionsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-10-27

Share capital

8,000.00 PLN

Activity description

Oxymotion is a company that offers the Q-LAC device, which provides real-time monitoring of muscle lactate levels and oxygenation during exercise. The device is compatible with Garmin, allowing users to analyze their performance data directly in the Garmin ecosystem. It enables athletes to adjust their training intensity based on accurate, non-invasive measurements, improving their workout efficiency.

Registered address

ul. Bohdana Dobrzańskiego 3, 20-262 Lublin, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 40 days for 2021).

2025not filed
202429/07/2025
202309/07/2024
202224/07/2023
202124/08/2022
202005/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Sanctions and PEP lists

Person	List	Match
Wojciech Nowak	Rektor Uniwersytetu Jagiellońskiego	confirmed

Industry

Research and experimental development on biotechnology (72.11.Z)Primary

Authorized Representatives

Mateusz Delikat – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented independently by the sole member of the management board. In the case of a multi-member management board, the company is represented by two members of the management board acting jointly.

Supervisory board

Marek Dworak – Supervisory Board Member

Krzysztof Łukasik – Supervisory Board Member

Michał Latacz – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Mateusz Delikatage 34	101	$1,364.13	63.125%
Human Alfa Spółka z Ogranczoną Odpowiedzialnością Asi sp. k.	43	$580.77	26.875%
Others	16	$216.10	10%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2021-02-01 to 2026-06-22.

Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)

Debt

2 closed proceedings recorded in KRZ history.

Registration date	Proceeding type	Status
Jun 18, 2024	Petition to declare entrepreneur bankruptcy	Closed
Jun 6, 2024	Petition to declare entrepreneur bankruptcy	Closed

MSiG notices

Publication date	Event
Mar 11, 2022	Call to creditors
Oct 22, 2021	Call to creditors
Jul 5, 2021	Call to creditors

Public aid

Grant date	Purpose	Gross amount	Granting body
Dec 3, 2020	Aid for SME access to finance — aid for start-ups	$205.1K$205,139	Dyrektor Narodowego Centrum Badań i Rozwoju

Competitors

	Name	Revenue	Website
	SatroecgS.A.	$117,301.57	satroecg.pl
	Advanced Diagnostic Equipmentsp. z o.o.	$43,171.56	adediabetics.pl

Change history

Date	Event
2023-06-20	Address change (Ul. Tomasza Zana 39a, 20-634, Lublin → Ul. Bohdana Dobrzańskiego 3, 20-262, Lublin)
2022-12-13	Share capital increase (7,200.00 PLN → 8,000.00 PLN)
2021-02-03	Share capital increase (5,000.00 PLN → 7,200.00 PLN)
2020-10-27	Entered in the register

FAQ

Last updated: 2026-06-11